Clinical Validation Q416 Oct 2020 22:34
It is essential that a robust process is developed that can produce the antigen test at scale for clinical validation in Q4, and good progress is being made in this regard. Once a robust process has been established it should be straightforward to transfer that to a number of manufacturers globally to meet the anticipated demand.
From 28th Sept RNS.
I believe Boris has confirmed the pilot batch will be ready for testing in the next few weeks.